findmyKOL

Sanjay Dandamudi, MD

Basic profile

Van Andel Institute

ORCIDNPI
RegionGrand Rapids, MI · MidwestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sanjay Dandamudi is a Cardiology physician affiliated with Van Andel Institute. OpenAlex indexes 36 publications with 386 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex, matched via ORCID.

386citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2900 Bradford St NE
Grand Rapids, MI 495256427

Telephone

616-885-5000

Provider last certified this registry record 24 Feb 2021.

View the NPPES registry record

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    58.9%
    Beta blocker24.9%
    Metoprolol Succinate70%Sotalol18%Metoprolol Tartrate6%Carvedilol5%Nebivolol Hcl2%
    Part D<11 patients
    Antiarrhythmic21.9%
    Flecainide Acetate46%Amiodarone Hcl37%Dofetilide8%Mexiletine Hcl8%Quinidine Gluconate2%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    40.5%
    Factor Xa inhibitor40%
    Eliquis81%Xarelto19%
    Part D261 patients
    Direct thrombin inhibitors0.6%
    Dabigatran Etexilate100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    0.6%
    Proton pump inhibitor0.6%
    Omeprazole100%
    Part D17 patients
Where care is delivered (Part B)27.2% facility · 72.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”